SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Bipin Prasad who wrote (22654)1/4/2000 9:32:00 AM
From: Mkilloran  Read Replies (2) | Respond to of 23519
 
Frostman..Astra will also pay the $2 mill fee for licence approval in Italy and will supply approved countries for the next 12 months.

This allows VVUS time to line up a new partner to launch Alibra the 2nd generation product. More cash onhand to feed the R&D pipeline to move forward with the Female orgasm cream and the oral pill for Premature Ejaculation...